BERKELEY, Calif. and MAINZ, Germany, Nov. 05, 2021 (GLOBE NEWSWIRE) Mainz Biomed N.V. (Nasdaq:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostics company specializing in the
BERKELEY, Calif. and MAINZ, Germany, Nov. 05, 2021 (GLOBE NEWSWIRE) Mainz Biomed N.V. (Nasdaq:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostics company specializing in the